ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF
Clinical trial NCT02056938 · TERMINATED
Trial details
- NCT number
- NCT02056938
- Sponsor
- Nantes University Hospital
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2017-02-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.